SiddharthSinghMD

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Physician

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9500 Gilman Dr
# Mail
La Jolla, CA 92093
Phone+1 619-543-2347

Fax+1 858-657-7259

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2011 - 2014
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2008 - 2011
All India Institute of Medical SciencesClass of 2007

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients Start of enrollment: 2020 Dec 18
Recruiting
Phase 2
Roles: Contact, Principal Investigator

PubMed

2 citations
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease.
Sudheer K Vuyyuru, Christopher Ma, Tanmay Sharma, Tran M Nguyen, Talat Bessissow
Inflammatory Bowel Diseases. 2024-11-04
Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies.
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Siddharth Singh, Ashwin N Ananthakrishnan
Alimentary Pharmacology & Therapeutics. 2024-11-01
No Impact of Concomitant Medications on Efficacy and Safety of Biologics and Small Molecules for Ulcerative Colitis.
Dhruv Ahuja, Guangyong Zou, Virginia Solitano, Gaurav Syal, Han Hee Lee
Clinical Gastroenterology and Hepatology. 2024-10-11

Journal Articles

Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases
Waseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
No Benefit of Concomitant 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data from Cli...
Siddharth Singh, Parambir S Dulai, William J Sandborn, Nature
Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials
Siddharth Singh, William J Sandborn, Nature

New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UCNovember 26th, 2024
New AGA Guidance for Ulcerative Colitis Treatment: 8 Things to KnowNovember 25th, 2024
Guidelines Endorse Earlier Use of High-Efficacy Drugs for UCNovember 25th, 2024
Join now to see all